查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928662

血栓切除真空吸引幫浦市場（按幫浦類型、流速、導管尺寸、應用和最終用戶分類），全球預測，2026-2032年

Thrombectomy Aspiration Negative Pressure Pump Market by Pump Type, Flow Rate, Catheter Size, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年血栓切除真空幫浦市場價值為 1.6618 億美元，預計到 2026 年將成長至 1.7965 億美元，預計到 2032 年將達到 2.856 億美元，複合年成長率為 8.04%。

關鍵市場統計數據
基準年 2025 1.6618億美元
預計年份：2026年 1.7965億美元
預測年份 2032 2.856億美元
複合年成長率 (%) 8.04%

權威地介紹了負壓血栓抽吸泵在現代血管內治療和手術流程發展中的地位

用於血栓切除術的負壓抽吸幫浦已成為血管內治療的核心工具，有助於在急性缺血事件中快速清除血栓，並拓展神經血管和周邊介入治療的手術選擇。這些幫浦提供可控制的抽吸力，以輔助基於抽吸的血栓切除術，並且與現代導管系統聯合使用時，可提高血栓的捕獲和清除率。臨床醫生越來越依賴設備的人體工學設計、流量控制以及與抽吸導管的兼容性，以最佳化手術時間和患者預後。

簡潔地整合了核心技術、營運和護理服務的變革，重新定義了吸痰幫浦的價值提案和臨床應用。

器械工程、臨床技術和醫療服務模式的同步進步帶來了多項變革性變化，正在重塑血栓切除抽吸泵領域。首先，技術改進主要集中在精確的流量控制、封閉回路型安全功能和器械小型化方面，這些改進提高了抽吸性能的穩定性，並使其能夠順利整合到空間有限的手術室中。這些工程改進，加上導管設計的最佳化（可提高血栓捕獲率並減少遠端栓塞），正在提高以抽吸為先導策略的手術成功率。

本文分析了近期關稅如何重塑醫療設備價值鏈的籌資策略和製造因應措施。

美國2025年實施的關稅和貿易調整措施對醫療設備製造商和供應商的供應鏈策略、成本結構和製造地選址產生了重大影響。真空幫浦的關鍵部件（例如精密馬達、微控制器、管路組件和特殊聚合物）通常來自全球各地。為了應對關稅帶來的成本壓力，許多製造商正在重新審視其供應商結構，加速多元化發展，減少對單一國家的依賴，並在條件允許的情況下擴大近岸外包和國內組裝。

對終端用戶類型、幫浦架構、應用需求、流體動力學和導管尺寸進行詳細的分段觀點，並與籌資策略和臨床策略保持一致。

市場區隔揭示了設備選擇、採購行為和臨床應用的細微差別，這些差別會影響商業策略和產品開發。在分析終端使用者時，門診手術中心分為醫院附屬機構和獨立機構，二者的資本預算、人員配備模式和容量預期各不相同。診所分為循環系統和介入放射學兩個專科，每個專科的病例組合和一次性醫療器械偏好也各不相同。醫院的規模從大型三級醫療中心到中小型社區醫院不等，每家醫院的手術量、訓練資源和採購週期都各有不同。

美洲、歐洲、中東和非洲以及亞太地區臨床基礎設施監管差異和採購因素的比較分析

區域差異正在影響美洲、歐洲、中東和非洲以及亞太地區抽吸幫浦系統的臨床應用、監管預期和商業性策略。在美洲，強大的卒中網路、先進的血管內基礎設施以及對三級醫療中心的重點資本投入，推動了對支持尖端神經和外周介入治療的高性能系統的需求。許多地區的報銷機制和集中式中風診療路徑促進了技術的快速普及，但採購者也追求可證明的臨床價值和成本控制。

對吸泵解決方案領域競爭定位、創新夥伴關係和策略性舉措的實用概述，這些因素共同定義了產業領導地位。

血栓切除抽吸幫浦領域的競爭格局呈現出多元化的態勢，既有成熟的醫療設備製造商，也有專注於介入治療的專業公司，還有致力於利基創新的敏捷型Start-Ups。成熟的醫療器材製造商利用其豐富的產品系列和廣泛的分銷網路，將抽吸泵與配套的導管和耗材捆綁銷售。同時，專注於介入治療領域的企業則強調差異化的泵體人體工學設計、模組化耗材系統以及以臨床醫生為中心的介面，以贏得手術領域的認可。

為製造商、供應商和採購商提供一系列切實可行、影響深遠的建議，以增強其韌性、推動產品普及並展現其臨床和經濟價值。

產業領導者可以採取一系列切實可行的策略來鞏固市場地位、改善臨床療效並降低供應鏈風險。首先，透過多元化採購管道，降低關稅波動和物流中斷帶來的風險。具體做法包括：對多家關鍵零件供應商進行資格認證，並探索近岸外包和區域製造夥伴關係。這種方法既能增強韌性，又能為醫院和診所提供更可預測的前置作業時間。

透明的混合調查方法：結合面對面專家訪談、文獻綜述、監管分析和供應鏈圖譜分析，以得出可靠的研究結果。

本研究採用混合方法，結合一手質性研究和二手資料，對證據進行篩選和三角驗證，從而綜合分析研究結果。一手研究包括對神經血管和周圍血管專家、門診手術中心、醫院和診所的採購主管以及醫療設備設計和供應鏈管理方面的技術專家進行結構化訪談。這些訪談有助於解讀器材效能考量、臨床工作流程和採購促進因素。

簡潔扼要的結論，綜合臨床、技術和商業性因素，為吸泵應用的策略決策提供指導。

總之，真空幫浦在現代血管內治療中佔有重要的地位，它能夠實現神經血管和周邊介入治療中的「先抽吸後介入」技術。流量控制、人體工學和耗材方面的技術進步，以及醫療服務模式的演變和門診手術的普及，正在催生出微妙的需求，並需要製定靈活的產品策略。同時，關稅趨勢和供應鏈的波動凸顯了採購柔軟性和可製造性設計的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 血栓切除真空吸引幫浦市場（按幫浦類型分類）

  • 隔膜式
  • 蠕動
  • 活塞式
  • 旋轉

9. 按流量分類的血栓切除真空幫浦市場

  • 高流速
  • 低流量
  • 中等流速

10. 按導管尺寸分類的血栓切除真空幫浦市場

  • 大的
  • 中等的
  • 小的

第11章 負壓真空血栓切除幫浦市場（按應用領域分類）

  • 神經血栓切除術
  • 周邊血栓切除術

第12章 負壓真空血栓切除幫浦市場（依最終用戶分類）

  • 門診手術中心
    • 醫院附屬機構
    • 獨立
  • 診所
    • 循環系統
    • 介入放射學
  • 醫院
    • 大型醫院
    • 中型醫院
    • 小規模醫院

13. 血栓切除真空幫浦市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 負壓真空血栓切除幫浦市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國血栓切除真空幫浦市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國血栓切除真空幫浦市場

17. 中國：負壓血栓切除幫浦市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Imperative Care, Inc.
  • Inari Medical, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • NeuroVasc Technologies, Inc.
  • Nico Corporation
  • Penumbra, Inc.
  • Route 92 Medical, Inc.
  • Shandong Weigao Group Medical Polymer Co., Ltd.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio, LLC
  • Wallaby Medical, Inc.
Product Code: MRR-92740D85F09B

The Thrombectomy Aspiration Negative Pressure Pump Market was valued at USD 166.18 million in 2025 and is projected to grow to USD 179.65 million in 2026, with a CAGR of 8.04%, reaching USD 285.60 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 166.18 million
Estimated Year [2026] USD 179.65 million
Forecast Year [2032] USD 285.60 million
CAGR (%) 8.04%

An authoritative introduction that situates negative pressure thrombectomy aspiration pumps within modern endovascular practice and procedural workflow evolution

Thrombectomy aspiration negative pressure pumps have emerged as central tools in endovascular therapy, supporting rapid clot extraction in acute ischemic events and expanding procedural options across neurovascular and peripheral interventions. These pumps provide controlled suction to facilitate aspiration-based thrombectomy techniques, improving clot engagement and removal when used alongside contemporary catheter systems. Clinicians increasingly rely on device ergonomics, flow modulation, and compatibility with aspiration catheters to optimize procedure times and patient outcomes.

Clinical teams, hospital administrators, and procurement specialists view these pumps through multiple lenses: procedural efficacy, safety profile, ease of integration into existing workflows, and total procedural cost. As stroke systems of care evolve to prioritize rapid reperfusion, device reliability and predictable performance under variable hemodynamic conditions have become essential. Meanwhile, the shift of certain interventional procedures to outpatient settings has increased scrutiny on pump portability, footprint, and disposable consumable economics. Therefore, device design decisions now must balance high-performance characteristics with usability and cost containment.

Regulatory pathways and evolving clinical guidelines continue to shape adoption patterns. Real-world evidence from registries and single-center experiences is informing best practices for pump use in both neuro and peripheral thrombectomy. As a result, stakeholders across the clinical, operational, and commercial spectrum are actively reassessing procurement criteria to align with emerging standards of care and the operational realities of contemporary vascular intervention suites.

A concise synthesis of the core technological operational and care delivery shifts that are redefining aspiration pump value propositions and clinical adoption

Several transformative shifts are reshaping the thrombectomy aspiration pump landscape, driven by concurrent advances in device engineering, clinical technique, and care delivery models. First, technological refinement has focused on precision flow control, closed-loop safety features, and reductions in device bulk, which together enable more consistent aspiration performance and smoother integration into constrained procedure rooms. These engineering improvements have coincided with refinements in catheter design that enhance clot capture and reduce distal embolization, thereby increasing the procedural success of aspiration-first strategies.

Second, procedural protocols and training have adapted to incorporate aspiration pumps more routinely, with multidisciplinary teams standardizing techniques that blend aspiration and mechanical thrombectomy where appropriate. Consequently, the skill set required of operators has broadened, prompting investment in simulation and proctoring programs. Third, the migration of select interventions into ambulatory surgical centers and outpatient clinics has raised demand for portable, low-noise, and battery-capable pump platforms that support shorter turnover times and simplified sterilization workflows.

Finally, market dynamics are influenced by broader medtech trends such as modular product architectures, consumable optimization, and connectivity for device telemetry. As a result, manufacturers that prioritize interoperable systems, clinician-centric interfaces, and evidence generation are well positioned to capitalize on the clinical momentum behind aspiration-based strategies. Collectively, these shifts herald a more integrated, clinician-driven model of device development and adoption.

A focused analysis of how recent tariff measures have reshaped supply chains procurement calculus and manufacturing responses across the device value chain

The imposition of tariffs and trade adjustments in the United States in twenty twenty five has exerted a material influence on supply chain strategies, cost structures, and manufacturing footprints for device makers and suppliers. Components integral to negative pressure aspiration pumps, including precision motors, microcontrollers, tubing assemblies, and specialized polymers, are often sourced globally. In response to tariff-driven cost pressure, many manufacturers have re-evaluated their supplier matrices, accelerating diversification away from single-country dependencies and increasing nearshoring or domestic assembly where feasible.

As firms adjust procurement and production to mitigate tariff impacts, they face trade-offs between unit manufacturing cost, inventory carrying costs, and time-to-market for product iterations. These dynamics have prompted renewed emphasis on design for manufacturability, supplier consolidation to leverage volume discounts, and inventory hedging strategies. From a hospital procurement perspective, increased component cost can translate into higher capital or disposable pricing, prompting more rigorous total cost of ownership analyses and longer-term service contracts to stabilize expenditures.

Moreover, tariff-related shifts have prompted regulatory and compliance teams to reassess documentation around country of origin and supply chain traceability. In the medium term, stakeholders may see a prioritization of strategic partnerships, contract manufacturing in tariff-favored jurisdictions, and targeted investments in automated assembly to offset labor and logistics costs. Consequently, organizations that proactively manage sourcing flexibility and maintain transparent cost models will be better equipped to sustain competitive positioning while ensuring uninterrupted clinical supply.

An in-depth segmentation-driven perspective that aligns end user types pump architectures application needs flow dynamics and catheter sizing with procurement and clinical strategy

Segmentation reveals nuanced patterns of device selection, procurement behavior, and clinical application that influence commercial strategy and product development. When examining end users, ambulatory surgical centers differentiate between hospital-affiliated and independent facilities, each with distinct capital budgets, staffing models, and throughput expectations; clinics segregate into cardiovascular-focused and interventional radiology-focused practices with differing case mixes and disposable preferences; and hospitals range from large tertiary centers to medium and small community hospitals, each presenting unique procedural volumes, training resources, and purchasing cycles.

Device selection also varies by pump type, with diaphragm systems favored for precise low-flow control in delicate neurovascular applications, peristaltic pumps offering robust continuous flow for longer peripheral procedures, piston pumps delivering rapid high-suction bursts for challenging clot burden scenarios, and rotary designs balancing compactness with steady-state aspiration. Application-specific considerations separate neuro thrombectomy from peripheral thrombectomy, as neuro cases demand tighter flow regulation and catheter compatibility for intracranial navigation while peripheral interventions prioritize higher volume capacity and durability under variable vessel calibers.

Flow rate segmentation-high flow, medium flow, and low flow-further informs clinical pairing of pumps with catheter size selections categorized as large, medium, and small. High-flow pumps pair with large catheters to expedite bulk clot removal in peripheral vessels, whereas low-flow pumps tuned to small catheter systems are critical for intracranial access where vessel preservation is paramount. These intersecting segmentation axes drive procurement choices, clinician training priorities, and product roadmaps that align specific pump architectures to the nuanced needs of disparate procedural settings.

A comparative regional analysis that maps clinical infrastructure regulatory nuance and procurement drivers across the Americas Europe Middle East and Africa and Asia Pacific

Regional differences shape clinical adoption, regulatory expectations, and commercial approaches for aspiration pump systems across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, robust stroke networks, advanced endovascular infrastructure, and concentrated capital investment in tertiary care centers drive demand for high-performance systems that support leading-edge neuro and peripheral interventions. Reimbursement frameworks and centralized stroke care pathways in many jurisdictions encourage rapid technology adoption, but purchasers also demand demonstrable clinical value and cost containment.

Across Europe Middle East and Africa, heterogeneous regulatory environments and fragmented procurement landscapes require tailored market access strategies. Countries with centralized health technology assessment frameworks place greater emphasis on clinical evidence and health economic modeling, while emerging markets within the region prioritize device affordability and supply chain reliability. In addition, cross-border distribution complexities and variable hospital budgets influence the adoption pace for premium pump platforms.

The Asia-Pacific region presents a mix of advanced tertiary centers in metropolitan hubs and rapidly growing procedural volumes in secondary cities. Local manufacturing capacity, government procurement initiatives, and evolving reimbursement schemes are key determinants of market dynamics. Importantly, device makers seeking regional expansion must navigate diverse regulatory regimes, invest in local clinical validation, and adapt product configurations to meet the operational realities of both high-volume metropolitan hospitals and resource-constrained facilities.

A practical overview of competitive positioning innovation partnerships and strategic moves that determine leadership in aspiration pump solutions

Competitive dynamics in the thrombectomy aspiration pump arena reflect a mix of established medical device firms, specialist interventional companies, and agile startups focused on niche innovations. Incumbent device manufacturers leverage broad portfolios and extensive distribution networks to bundle aspiration pumps with complementary catheters and consumables, while focused players emphasize differentiated pump ergonomics, modular consumable systems, and clinician-centric interfaces to capture procedure-oriented mindshare.

Partnerships between pump makers and catheter developers have become increasingly common, enabling seamless compatibility and streamlined procurement for hospitals and clinics. In parallel, several companies invest in controlled clinical programs and registry participation to build evidence supporting aspiration-first approaches, while others prioritize cost-per-procedure reductions through reusable components or lower-cost disposables. Investment activity continues in R&D areas such as quieter motor assemblies, battery-assisted portability, and intuitive user interfaces that reduce training time and procedural complexity.

New entrants and smaller firms often catalyze innovation by introducing disruptive features, which prompts established players to accelerate product refresh cycles or pursue strategic acquisitions. Ultimately, success in this competitive landscape depends on a clear value proposition that addresses clinician workflow, demonstrable procedural benefits, and sustainable economics for both capital buyers and high-volume settings.

A set of pragmatic high impact recommendations for manufacturers providers and purchasers to strengthen resilience drive adoption and demonstrate clinical economic value

Industry leaders can adopt a set of actionable strategies to strengthen market position, improve clinical outcomes, and mitigate supply chain risks. First, diversify sourcing by qualifying multiple suppliers for critical components and exploring nearshoring or regional manufacturing partnerships to reduce exposure to tariff volatility and logistics disruptions. This approach improves resilience while enabling more predictable lead times for hospitals and clinics.

Second, prioritize modular product design that supports multiple clinical applications through interchangeable consumables and configurable flow profiles. Such flexibility enhances value for facilities that manage both neuro and peripheral caseloads and facilitates scaling across ambulatory centers, clinics, and hospitals. Third, invest in clinician training programs and evidence generation, including prospective registries and procedural efficiency studies, to substantiate claims around workflow improvements and patient outcomes. These efforts also support reimbursement conversations and health technology assessments.

Fourth, pursue interoperability and user-centered interfaces to reduce the learning curve and improve adoption in diverse care settings. Finally, engage procurement and clinical stakeholders early to design pricing and service models that reflect total cost of ownership, including consumables, maintenance, and training. By adopting these strategies, companies can unlock broader adoption and create defensible differentiation in a competitive marketplace.

A transparent explanation of the mixed methods research approach combining direct expert engagement literature review regulatory analysis and supply chain mapping for robust insights

The study synthesizes insights through a mixed methods approach that combines primary qualitative engagement with secondary evidence triage and triangulation. Primary research included structured interviews with clinicians across neurovascular and peripheral specialties, procurement leaders at ambulatory surgical centers hospitals and clinics, and technical experts in device engineering and supply chain management. These discussions informed interpretation of device performance considerations clinical workflows and purchasing drivers.

Secondary research involved systematic review of peer reviewed clinical literature device labeling and regulatory filings to establish a foundation of clinical and technical fidelity. In addition, device registries and procedural outcome datasets were examined to understand real-world usage patterns and operational metrics. Supply chain mapping leveraged trade data and supplier disclosures to illuminate sourcing patterns and tariff sensitivity. All findings were validated through cross-referencing multiple independent sources and iterative analyst review, ensuring a robust, evidence-driven narrative.

Where quantitative comparisons were used to illustrate trends, values and assumptions were transparently linked to source material and subject-matter experts were engaged to confirm interpretive judgments. This methodology ensures that insights reflect both clinical realities and commercial constraints relevant to stakeholders evaluating aspiration pump strategies.

A concise conclusion that synthesizes clinical technological and commercial imperatives to guide strategic decisions in aspiration pump deployment

In summary, negative pressure aspiration pumps occupy a critical niche in contemporary endovascular therapy by enabling aspiration-first techniques across neuro and peripheral interventions. Technological advances in flow control, ergonomics, and consumable pairing, together with evolving care delivery models and procedural migration into ambulatory settings, are driving nuanced demand that requires tailored product strategies. Meanwhile, tariff developments and supply chain volatility underscore the importance of sourcing flexibility and design for manufacturability.

Segmentation analysis reveals that end user heterogeneity, pump architecture, application-specific needs, flow rate considerations, and catheter sizing jointly determine procurement decisions and clinical adoption. Regional differences further modulate market opportunities, with mature systems demanding high-performance integrated solutions and emerging markets prioritizing affordability and supply reliability. Competitive dynamics favor organizations that combine clinical evidence generation with clinician-centric product design and resilient commercial models.

Collectively, these insights point to strategic priorities for stakeholders: align product development with procedural workflows, invest in evidence and training, de-risk supply chains, and adopt flexible pricing and service offerings. By doing so, manufacturers and health system purchasers can better meet clinical needs while navigating the operational and regulatory complexities of contemporary vascular intervention practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Thrombectomy Aspiration Negative Pressure Pump Market, by Pump Type

  • 8.1. Diaphragm
  • 8.2. Peristaltic
  • 8.3. Piston
  • 8.4. Rotary

9. Thrombectomy Aspiration Negative Pressure Pump Market, by Flow Rate

  • 9.1. High Flow
  • 9.2. Low Flow
  • 9.3. Medium Flow

10. Thrombectomy Aspiration Negative Pressure Pump Market, by Catheter Size

  • 10.1. Large
  • 10.2. Medium
  • 10.3. Small

11. Thrombectomy Aspiration Negative Pressure Pump Market, by Application

  • 11.1. Neuro Thrombectomy
  • 11.2. Peripheral Thrombectomy

12. Thrombectomy Aspiration Negative Pressure Pump Market, by End User

  • 12.1. Ambulatory Surgical Centers
    • 12.1.1. Hospital Affiliated
    • 12.1.2. Independent
  • 12.2. Clinics
    • 12.2.1. Cardiovascular
    • 12.2.2. Interventional Radiology
  • 12.3. Hospitals
    • 12.3.1. Large Hospitals
    • 12.3.2. Medium Hospitals
    • 12.3.3. Small Hospitals

13. Thrombectomy Aspiration Negative Pressure Pump Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Thrombectomy Aspiration Negative Pressure Pump Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Thrombectomy Aspiration Negative Pressure Pump Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Thrombectomy Aspiration Negative Pressure Pump Market

17. China Thrombectomy Aspiration Negative Pressure Pump Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Acandis GmbH & Co. KG
  • 18.7. AngioDynamics, Inc.
  • 18.8. Becton, Dickinson and Company
  • 18.9. Boston Scientific Corporation
  • 18.10. Cook Medical LLC
  • 18.11. Imperative Care, Inc.
  • 18.12. Inari Medical, Inc.
  • 18.13. Medtronic plc
  • 18.14. Merit Medical Systems, Inc.
  • 18.15. NeuroVasc Technologies, Inc.
  • 18.16. Nico Corporation
  • 18.17. Penumbra, Inc.
  • 18.18. Route 92 Medical, Inc.
  • 18.19. Shandong Weigao Group Medical Polymer Co., Ltd.
  • 18.20. Stryker Corporation
  • 18.21. Teleflex Incorporated
  • 18.22. Terumo Corporation
  • 18.23. Vesalio, LLC
  • 18.24. Wallaby Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY DIAPHRAGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY DIAPHRAGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PERISTALTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PERISTALTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PISTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PISTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PISTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY ROTARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY ROTARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY ROTARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HIGH FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HIGH FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HIGH FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LOW FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LOW FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LOW FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LARGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LARGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LARGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SMALL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SMALL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SMALL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY NEURO THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY NEURO THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY NEURO THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PERIPHERAL THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PERIPHERAL THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PERIPHERAL THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LARGE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY LARGE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY MEDIUM HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SMALL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SMALL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SMALL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 166. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 193. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 194. G7 THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 195. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 202. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 203. NATO THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CATHETER SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA THROMBECTOMY ASPIRATION NEGATIVE PRESSURE PUMP MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)